Mitochondrial permeability transition pore: a promising target for the treatment of Parkinson's disease

Protoplasma
Md Zeeshan RasheedSuhel Parvez

Abstract

Among the neurodegenerative diseases (ND), Parkinson's disease affects 6.3 million people worldwide characterized by the progressive loss of dopaminergic neurons in substantia nigra. The mitochondrial permeability transition pore (mtPTP) is a non-selective voltage-dependent mitochondrial channel whose opening modifies the permeability properties of the mitochondrial inner membrane. It is recognized as a potent pharmacological target for diseases associated with mitochondrial dysfunction and excessive cell death including ND such as Parkinson's disease (PD). Imbalance in Ca(2+) concentration, change in mitochondrial membrane potential, overproduction of reactive oxygen species (ROS), or mutation in mitochondrial genome has been implicated in the pathophysiology of the opening of the mtPTP. Different proteins are released by permeability transition including cytochrome c which is responsible for apoptosis. This review aims to discuss the importance of PTP in the pathophysiology of PD and puts together different positive as well as negative aspects of drugs such as pramipexole, ropinirole, minocyclin, rasagilin, and safinamide which act as a blocker or modifier for mtPTP. Some of them may be detrimental in their neuroprotective na...Continue Reading

References

Jan 1, 1991·Advances in Immunology·J J Cohen
Jun 20, 1998·The Journal of Biological Chemistry·T KuwanaS Kornbluth
Sep 30, 1998·Cell·D R Green
May 1, 1999·Journal of the Neurological Sciences·J P Bennett, M F Piercey
Jul 10, 1999·The Journal of Biological Chemistry·B B Wolf, D R Green
Jul 17, 1999·Neurobiology of Disease·L N Geller, H Potter
Mar 10, 2000·Biochimica Et Biophysica Acta·H R Stennicke, G S Salvesen
Jun 17, 2000·Trends in Neurosciences·M F Beal
Feb 22, 2001·Biochemical and Biophysical Research Communications·C M RodriguesJ J Moura
Oct 31, 2001·Nature Structural Biology·P BurkhardV N Malashkevich
Nov 29, 2001·Proceedings of the National Academy of Sciences of the United States of America·Y DuS M Paul
Apr 12, 2002·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Ranjita BetarbetJ Timothy Greenamyre
Feb 18, 2004·Current Pharmaceutical Design·M Thomas, W D Le
Dec 2, 2004·Journal of Neuroscience Research·Moussa B H YoudimTamar Amit
Feb 25, 2005·QJM : Monthly Journal of the Association of Physicians·A C WilliamsD B Ramsden
Jan 13, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Iqbal SayeedDetlef Siemen
Apr 22, 2006·Biochimica Et Biophysica Acta·Alexandra KrauskopfPaolo Bernardi
May 3, 2006·The FEBS Journal·Paolo BernardiMichael A Forte
Feb 13, 2007·Apoptosis : an International Journal on Programmed Cell Death·Kathleen W Kinnally, Bruno Antonsson
Apr 3, 2007·Neurochemistry International·M D Norenberg, K V Rama Rao
Apr 10, 2007·Nature Cell Biology·Christopher P BainesJeffery D Molkentin
Nov 6, 2007·Lancet Neurology·Paul H GordonUNKNOWN Western ALS Study Group
Apr 15, 2008·Biochimica Et Biophysica Acta·Anna W C Leung, Andrew P Halestrap
Aug 6, 2008·Journal of Neurochemistry·Miquel VilaCeline Perier
Nov 22, 2008·Cell Death and Differentiation·G KrumschnabelA Villunger
Dec 9, 2008·Biochimica Et Biophysica Acta·Rebecca BanerjeeBobby Thomas
Mar 10, 2009·Biochimica Et Biophysica Acta·Fulvio CelsiRosario Rizzuto
Mar 11, 2009·Frontiers in Bioscience (Landmark Edition)·Robert F FeissnerShey-Shing Sheu
Sep 8, 2009·Biochimica Et Biophysica Acta·Konstanze F Winklhofer, Christian Haass
May 25, 2010·Nature Medicine·Jose A ObesoGlenda Halliday
Jul 6, 2010·Progress in Neurobiology·Orly WeinrebMoussa B H Youdim
Dec 2, 2010·Molecular Neurobiology·Inês Pimenta de CastroSamantha Hui Yong Loh
Apr 8, 2011·Current Alzheimer Research·P H Reddy, T P Reddy
May 17, 2011·Antioxidants & Redox Signaling·Melissa K McCoy, Mark R Cookson
May 24, 2011·Cell Calcium·Andrea Rasola, Paolo Bernardi
Jun 1, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Anthony H Schapira, Peter Jenner
Jun 15, 2011·Antioxidants & Redox Signaling·Kah-Leong LimTso-Pang Yao

❮ Previous
Next ❯

Citations

Dec 8, 2017·Frontiers in Neuroscience·Leanne T Y CheungKin Chiu
Aug 6, 2019·Chemical Communications : Chem Comm·Yu GengYouqing Shen
Jul 8, 2020·Antioxidants·Han-A Park, Amy C Ellis
Jun 27, 2019·Disease Models & Mechanisms·Syed Suhail AndrabiSuhel Parvez
Apr 29, 2020·Journal of Computational Biology : a Journal of Computational Molecular Cell Biology·Rutvi Prajapati, Isaac Arnold Emerson
Dec 5, 2018·Toxicology Research·Long MaJia-Xin Dong
Aug 28, 2020·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Zeinab VahidiniaMohammad Taghi Joghataei
Mar 31, 2021·Molecular Metabolism·Riya ShresthaFrances L Byrne
Sep 3, 2018·Free Radical Biology & Medicine·Anibal E VercesiEstela N B Busanello

❮ Previous
Next ❯

Methods Mentioned

BETA
ubiquitination

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis